Asahi Life Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,285
| Closed | -$378K | – | 206 |
|
|
2024
Q3 | $378K | Buy |
+3,285
| New | +$378K | 0.23% | 117 |
|
|
2023
Q4 | – | Sell |
-2,565
| Closed | -$289K | – | 207 |
|
|
2023
Q3 | $289K | Sell |
2,565
-575
| -18% | -$64.7K | 0.1% | 130 |
|
|
2023
Q2 | $296K | Buy |
3,140
+500
| +19% | +$47.2K | 0.1% | 150 |
|
|
2023
Q1 | $267K | Buy |
+2,640
| New | +$267K | 0.08% | 164 |
|